SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,424,000 | -0.4% | 395,044 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $4,441,000 | +12.6% | 403,714 | +0.3% | 0.00% | -20.0% |
| Q1 2017 | $3,945,000 | -5.3% | 402,500 | +4.4% | 0.01% | 0.0% |
| Q4 2016 | $4,165,000 | +11.9% | 385,658 | +6.2% | 0.01% | 0.0% |
| Q3 2016 | $3,723,000 | -18.8% | 363,174 | +3.4% | 0.01% | -16.7% |
| Q2 2016 | $4,587,000 | +3323.1% | 351,202 | +2475.7% | 0.01% | – |
| Q2 2015 | $134,000 | +3.9% | 13,635 | -6.5% | 0.00% | – |
| Q1 2015 | $129,000 | +4.0% | 14,584 | +3.2% | 0.00% | – |
| Q4 2014 | $124,000 | -3.1% | 14,138 | -23.7% | 0.00% | – |
| Q3 2014 | $128,000 | +32.0% | 18,531 | 0.0% | 0.00% | – |
| Q2 2014 | $97,000 | -15.7% | 18,531 | -26.4% | 0.00% | – |
| Q1 2014 | $115,000 | -10.2% | 25,166 | -1.2% | 0.00% | – |
| Q4 2013 | $128,000 | -1.5% | 25,472 | -0.4% | 0.00% | – |
| Q3 2013 | $130,000 | -3.7% | 25,586 | -6.1% | 0.00% | – |
| Q2 2013 | $135,000 | – | 27,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |